Our Foundation
Where We've Been.
Brodeur Foundation marks 10 years of bringing good from tragedy. Published March 15, 2016 6:57PM. The Day The success of the Terri Brodeur Breast Cancer Foundation is proof that out of great tragedy can come great good. Breast cancer killed Terri Brodeur in 2005, her 41st year, leaving behind three children and a husband. Before […]
More 2015 Fundraising Results At TBBCF, we are in awe of the generous giving by so many individuals, teams, and companies over the years. It was no different in 2015. As you can see in these pictures, it is easy to smile when we think about how these efforts make a difference in the fight […]
Eneda Toska, PhD Memorial Sloan Kettering Cancer Center Mutations in the PIK3CA gene are the most frequent genomic alterations in estrogen receptor (ER)-positive breast cancers. One treatment strategy is the use of drugs that inhibit the gene’s signaling pathway—however, many patients eventually become resistant to this type of therapy. Further, PI3K signaling pathway inhibition has […]
Daniel G. Stover, MD Dana-Farber Cancer Institute The host immune system is critical in the control and elimination of tumors in many cancer types. In breast cancer, tumor infiltrating immune cells have been associated with both response to chemotherapy and overall outcome for patients. Understanding what immune cell populations infiltrate tumors may help guide which […]
Mihriban Karaayvaz, PhD Mass General Hospital Cancer Center Making a major impact on the incidence and lethality of breast cancer will require a detailed understanding of the early events in breast cancer development, particularly in women who are at the highest risk of developing these cancers such as those who carry mutations in the BRCA1/2 […]
Jean Albrengues, Ph.D. Ph.D. Cold Spring Harbor Laboratories Dr. Jean Albrengues’ 2016 Terri Brodeur Breast Cancer Foundation fellowship award focuses on the regulation of breast cancer dormancy by the tumor microenvironment. Metastatic breast cancer relapse occurring years after seemingly successful treatment is preceded by an interlude, termed dormancy when cancer remains non-proliferative and undetected at […]
January 27, 2016 CT-scan did NOT go as expected!!! When they went to administer the dye via IV, the vein collapsed causing the dye to be infiltrated. I’ve never seen techs move so fast!!!! They came rushing in and the doctor was there instantly. SO, I’m in the ER for observation for a couple hours at the […]
2016-Research-Grants-Awards-Announcment-01-21-16-sm-1
Happy 10th Birthday TBBCF! – Today is our birthday. Thanks to all of you, we have been keeping Logan’s Promise since February 6, 2006 … with over $3.4 million donation dollars directed to breast cancer research. Keeping Logan’s Promise – TBBCF Special Grants Edition Congratulations to the 2016 Grant Recipients Over $3.4 million and 34 research […]
our sponsors
Platinum & Diamond Partners
